IMGM Laboratories GmbH 22. August 2014

Dr. Michael Bonin is the new Managing Director

IMGM Laboratories GmbH announces the appointment of Dr. Michael Bonin as Managing Director The genomic service provider IMGM Laboratories GmbH is pleased to announce Dr. Michael Bonin (40) as additional Managing Director effective August 1st 2014. Michael Bonin will head the scientific and technical development of the IMGM Laboratories GmbH activities and will direct the business of IMGM together with the Managing Director and Founder Dr. Hanns-Georg Klein. “We are proud to have an exceptional biologist and experienced manager such as Dr. Michael Bonin joining the Executive Board of IMGM. His recognized scientific and technological expertise and management skills as well as the highly innovative genomic service strategies, he has developed with his team in Tuebingen will add a significant value to IMGM Laboratories GmbH.”, comments Dr. Klein. Dr. Michael Bonin, Managing Director at IMGM from August 1st 2014: “I am very much looking forward to working together with the excellent and experienced IMGM team on the continued development of technologies and methods which will help to find the best genomic solutions for our customers. Especially intriguing for me is the broad spectrum of projects including such current topics as pharmaceutical research, biomarker discovery and companion diagnostics which generates a fascinating working environment.”

IMGM Laboratories offers advanced genomic services focusing on METAGENOMICS, BIOMARKER DISCOVERY, BIODISTRIBUTION and PHARMACOGENETIC... [mehr]